Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
Figure 3
Docking poses of the ligands with CDK2 binding sites. (a) Tetrahydropalmatine, (b) Reserpiline, (c) (+)-Corydaline, and (d) Dinaciclib. Pink dashed line: charge interaction; green dashed line: H-bond with amino acids main chains; blue dashed line: H-bond with amino acids side-chains; orange line: bond.